About the Editor: David Simmons, MD, MBBS, FRACP, FRCP-Rural Health Access and the TOBOGM Study.

Diabetes Care · 1 Oct 2026 · Editorial · Open access

Page

The abstract is read at the publisher; the summary is JClub's.

There's no AI summary of this paper here yet.

Open access

Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.

Clinical Guidance for Disease-Modifying Immunotherapy in Children and Adolescents With New-Onset (Stage 3) Type 1 Diabetes.
Diabetes Care · 11 Nov 2026 · Journal Article
AI summary · may contain errors
Teplizumab’s 2026 U.S. approval for children and adolescents aged 8–17 with new-onset stage 3 type 1 diabetes reshapes the first weeks after diagnosis.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/43012423
Open in JClub
Transient Cognitive Vulnerability After Hypoglycemia in Adults With Type 1 Diabetes: Evidence From Continuous Glucose Monitoring and Cognitive Ecologic Momentary Assessment.
Diabetes Care · 10 Nov 2026 · Journal Article
AI summary · may contain errors
Hypoglycemic events in adults with type 1 diabetes occurring within 0–1 h before smartphone cognitive testing are linked to slower reaction time and poorer DSM and GCPT performance.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/43007282
Open in JClub
Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study.
Diabetes Care · 2 Nov 2026 · Journal Article
AI summary · may contain errors
Lower fecal elastase-1 during the first 6 months of life predicts later multiple islet autoantibodies or type 1 diabetes in ENDIA children, with β-coefficients down to -0.61 at birth.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42969688
Open in JClub

Journals this month

All journals →

Topics moving, week to 13 Nov 2026

All topics →

By field

All journals by field →

About the Editor: David Simmons, MD, MBBS, FRACP, FRCP-Rural Health Access and the TOBOGM Study.

Related in JClub

Clinical Guidance for Disease-Modifying Immunotherapy in Children and Adolescents With New-Onset (Stage 3) Type 1 Diabetes.

Transient Cognitive Vulnerability After Hypoglycemia in Adults With Type 1 Diabetes: Evidence From Continuous Glucose Monitoring and Cognitive Ecologic Momentary Assessment.

Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study.

Browse JClub